Evidence map›Paper›PMID 34944987›Full record

ArticleCancers2021

Cobaltabis(dicarbollide) ([

Miquel Nuez-Martinez, Catarina I G Pinto, Joana F Guerreiro, Filipa Mendes, Fernanda Marques, Amanda Muñoz-Juan, Jewel Ann Maria Xavier, Anna Laromaine, Valeria Bitonto, Nicoletta Protti and 3 more

Open access · goldAbstract read
In one paragraph

Article in Cancers, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
4.4field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 38 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Cobaltabis(Dicarbollide) [Pharmaceuticals (Basel, Switzerland) · 2024
    Article
  6. Review
  7. Synthesis of new representatives of ABeilstein journal of organic chemistry · 2024
    Article
  8. Review
  9. Review
  10. Cancer 3D Models for Metallodrug Preclinical Testing.International journal of molecular sciences · 2023
    Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 3 countries.

Miquel Nuez-MartinezInstitut de Ciència de Materials de Barcelona (ICMAB-CSIC), Campus UAB, 08193 Bellaterra, Spain.
Catarina I G PintoCentro de Ciências e Tecnologias Nucleares, Departamento de Engenharia e Ciências Nucleares, Instituto Superior Técnico, Universidade de Lisboa, 2695-066 Bobadela, Portugal.ORCID 0000-0002-4195-5810
Joana F GuerreiroCentro de Ciências e Tecnologias Nucleares, Departamento de Engenharia e Ciências Nucleares, Instituto Superior Técnico, Universidade de Lisboa, 2695-066 Bobadela, Portugal.ORCID 0000-0003-1960-603X
Filipa MendesCentro de Ciências e Tecnologias Nucleares, Departamento de Engenharia e Ciências Nucleares, Instituto Superior Técnico, Universidade de Lisboa, 2695-066 Bobadela, Portugal.ORCID 0000-0003-0646-1687
Fernanda MarquesCentro de Ciências e Tecnologias Nucleares, Departamento de Engenharia e Ciências Nucleares, Instituto Superior Técnico, Universidade de Lisboa, 2695-066 Bobadela, Portugal.ORCID 0000-0001-8440-5299
Amanda Muñoz-JuanInstitut de Ciència de Materials de Barcelona (ICMAB-CSIC), Campus UAB, 08193 Bellaterra, Spain.ORCID 0000-0001-9549-782X
Jewel Ann Maria XavierInstitut de Ciència de Materials de Barcelona (ICMAB-CSIC), Campus UAB, 08193 Bellaterra, Spain.
Anna LaromaineInstitut de Ciència de Materials de Barcelona (ICMAB-CSIC), Campus UAB, 08193 Bellaterra, Spain.
Valeria BitontoDepartment of Molecular Biotechnology and Health Sciences, University of Torino, 10126 Torino, Italy.ORCID 0000-0003-2138-0658
Nicoletta ProttiDepartment of Physics, University of Pavia, 27100 Pavia, Italy.
Simonetta Geninatti CrichDepartment of Molecular Biotechnology and Health Sciences, University of Torino, 10126 Torino, Italy.ORCID 0000-0003-2998-5424
Francesc TeixidorInstitut de Ciència de Materials de Barcelona (ICMAB-CSIC), Campus UAB, 08193 Bellaterra, Spain.
Clara ViñasInstitut de Ciència de Materials de Barcelona (ICMAB-CSIC), Campus UAB, 08193 Bellaterra, Spain.ORCID 0000-0001-5000-0277
Institut de Ciència de Materials de Barcelona · ESUniversity of Lisbon · PTUniversity of Turin · ITUniversity of Pavia · IT

Funding

Fundação para a Ciência e Tecnologia PTDC/BTM-TEC/29256/2017Fundação para a Ciência e Tecnologia UID/MULTI/04349/2019Government of Catalonia 2017SGR1720Government of Catalonia 2017SGR765Italian Association for Cancer Research IG 2019 - ID. 23267Severo Ochoa Programme for Centres of Excellence in R&D SEV-2015-0496Spanish Ministerio de Economía y Competitividad PID2019-106832RB-I00Spanish Ministerio de Economía y Competitividad RTI2018-096273-B-I00
6 · The paper itself

Abstract

purposeThe aim of our study was to assess if the sodium salt of cobaltabis(dicarbollide) and its di-iodinated derivative (Na[

methodsThe biological activities of the small molecules were evaluated in vitro with glioblastoma cells lines U87 and T98G in 2D and 3D cell models and in vivo in the small model animal

resultsOur studies indicated that only spheroids from the U87 cell line have impaired growth after treatment with both compounds, suggesting an increased resistance from T98G spheroids, contrary to what was observed in the monolayer culture, which highlights the need to employ 3D models for future GBM studies. In vitro tests in U87 and T98G cells conclude that the amount of

conclusionsThese small molecules, particularly [8,8'-I

Indexed as

3D cell modelsboron clustersboron neutron capture therapy (BNCT)C. elegansCOSANglioblastomain vitro BNCT effectmetallacarboranessmall molecules

Identifiers

PMID34944987
PMCPMC8699431
OpenAlexW4200427210

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.